MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
and sales of...
$316,180K
Proceeds from issuance of
common stock via...
$1,080K
Proceeds from issuance of
common stock through...
$524K
Net cash provided by
(used in) investing...
$192,799K
Net cash provided by
financing activities
$1,604K
Canceled cashflow
$123,381K
Net decrease in
cash, cash...
-$41,052K
Canceled cashflow
$194,403K
Stock compensation
expense
$62,419K
Depreciation expense
$3,557K
Impairment of intangible
asset
$2,300K
Prepaid expenses and
other current assets
-$1,612K
Loss on disposal of
property and equipment
-$1,003K
Purchases of investments
$122,971K
Purchases of property and
equipment
$410K
Net cash used in
operating activities
-$235,455K
Canceled cashflow
$70,891K
Net loss
-$276,479K
Accounts payable and
accrued expenses
-$11,440K
Deferred revenue
-$7,679K
Net amortization of
premiums and discounts on...
$4,949K
Operating lease assets and
liabilities, net
$4,272K
Other liabilities
-$1,527K
Back
Back
Cash Flow
source: myfinsight.com
Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. (RLAY)